Source: Annual Congress 2008 - Biomarkers and disease assessment in COPD
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
G. Baimakanova, S. Avdeev, P. Zubairova, K. Zykov, G. Tkachov, A. Chuchalin (Moscow, Russian Federation). N-terminal-pro-B-type natriuretic peptide (NT-proBNP) in patient with acute exacerbations (AE) of COPD. Eur Respir J 2008; 32: Suppl. 52, 3111

Member's Comments

No comment yet.

Related content which might interest you: B-type natriuretic peptide (BNP) in COPD patients with acute respiratory failure (ARF) Source: Annual Congress 2010 - COPD: cardiovascular comorbidities Year: 2010 Brain natriuretic peptide (BNP) determination in patients hospitalized for COPD exacerbation Source: Annual Congress 2008 - Biomarkers and disease assessment in COPD Year: 2008 Brain natriuretic peptide (BNP) levels during acute exacerbations of COPD – a novel biomarker Source: Annual Congress 2008 - Mechanisms of respiratory infections: interaction between the pathogen and the host Year: 2008 Presence of inspiratory crackles (IC) in stable chronic obstructive pulmonary disease (COPD) patients; correlation with plasma N-terminal pro-brain natriuretic peptide (NT-BNP) levels Source: Annual Congress 2008 - Assessment of the respiratory system Year: 2008 Diagnostic value of N-terminal pro-brain natriuretic peptide in patients with COPD with chronic hypoxemic respiratory failure. Source: Virtual Congress 2020 – COPD and the impact of comorbidities Year: 2020 The role of amino-terminal pro-brain natriuretic peptide (NT-proBNP in clinical evaluation of patient with acute exacerbation chronic obstructive pulmonary disease Source: International Congress 2014 – ICU outcomes, sepsis and infections Year: 2014 The use of plasma n-terminal pro B-type natriuretic peptide (proBNP) concentrations in differential diagnosis of comorbidity pulmonary patients Source: Annual Congress 2011 - Acute respiratory failure Year: 2011 The diagnostic value of N-terminal pro-C-type natriuretic peptide in COPD patients with pulmonary hypertension Source: International Congress 2015 – Pulmonary hypertension in lung disease Year: 2015 Effect of noninvasive ventilation (NIV) on left ventricular (LV) function, B-type natriuretic peptide (BNP) and markers of systemic inflammation in patients with refractory heart failure Source: Eur Respir J 2006; 28: Suppl. 50, 188s Year: 2006 Mid-regional pro-atrial natriuretic peptide and copeptin as indicators of disease severity and therapy response in CTEPH Source: ERJ Open Res, 6 (4) 00356-2020; 10.1183/23120541.00356-2020 Year: 2020 Use of B-type natriuretic peptide in the risk stratification of acute exacerbations of chronic obstructive pulmonary disease Source: Annual Congress 2008 - COPD Year: 2008 Pro-atrial natriuretic peptide and pro-vasopressin to predict severity and prognosis in community-acquired pneumonia Source: Eur Respir J 2007; 30: Suppl. 51, 481s Year: 2007 Effect of auto servo-ventilation (ASV) and continuous positive airway pressure (CPAP) on B-type natriuretic peptide (NT-proBNP) in patients with co-existing obstructive (OSA) and central sleep apnea (CSA) in heart failure (HF) Source: Annual Congress 2011 - Obstructive sleep apnoea: the heart and the brain Year: 2011 Does brain natriuretic peptide (BNP) at baseline influence the effects of nintedanib plus sildenafil in patients with IPF? Source: International Congress 2019 – Biomarkers and beyond in idiopathic interstitial pneumonia Year: 2019 Plasma n-terminal pro-brain natriuretic peptide (NT pro-BNP) level in respiratory diseases Source: Eur Respir J 2003; 22: Suppl. 45, 583s Year: 2003 Usefulness of serum (S) and pleural fluid (PF) levels of pro-brain natriuretic peptide (Pro-BNP) in the diagnosis of pleural transudates due to congestive heart failure (CHF) Source: Eur Respir J 2006; 28: Suppl. 50, 581s Year: 2006 The effect of diuretics on plasma brain natriuretic peptide level in patients with acute exacerbations of chronic obstructive pulmonary disease Source: Annual Congress 2007 - Treatment of COPD Year: 2007 N-terminal pro-brain natriuretic peptide in patients with acute pulmonary embolism Source: Eur Respir J 2003 Oct 01;22(4):649-653 Year: 2003 Brain natriuretic peptide (BNP) and right ventricular dysfunction predict survival in interstitial lung disease (ILD) Source: Annual Congress 2008 - Clinical aspects of interstitial lung disease Year: 2008 The incidence and significance of elevated B-type natriuretic peptide levels in patients hospitalized with apparent respiratory diseases Source: Eur Respir J 2004; 24: Suppl. 48, 279s Year: 2004